Abstract:Over the past decade, cancer immunotherapy has significantly advanced through the introduction of immune checkpoint inhibitors, and the augmentation of adoptive cell transfer to enhance the innate cancer defense mechanisms. Despite these remarkable achievements, some cancers exhibit resistance to immunotherapy, with limited patient responsiveness and development of therapy resistance. Metabolic adaptations in both immune cells and cancer cells have emerged as central contributors to immunotherapy resistance. In the last few years, new insights emphasized the critical role of cancer and immune cell metabolism in animal models and patients. During therapy, immune cells undergo important metabolic shifts crucial for their acquired effector function against cancer cells. However, cancer cell metabolic rewiring and nutrient competition within tumor microenvironment (TME) alters many immune functions, affecting their fitness, polarization, recruitment, and survival. These interactions have initiated the development of novel therapies targeting tumor cell metabolism and favoring anti-tumor immunity within the TME. Furthermore, there has been increasing interest in comprehending how diet impacts the response to immunotherapy, given the demonstrated immunomodulatory and anti-tumor activity of various nutrients. In conclusion, recent advances in preclinical and clinical studies have highlighted the capacity of immune-based cancer therapies. Therefore, further exploration into the metabolic requirements of immune cells within the TME holds significant promise for the development of innovative therapeutical approaches that can effectively combat cancer in patients.

Immunometabolism in cancer: A journey into innate and adaptive cells

Cancer immunometabolism: advent, challenges, and perspective

The interplay between metabolic adaptations and diet in cancer immunotherapy

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization

Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses

Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression

Immunometabolism in cancer: basic mechanisms and new targeting strategy

Metabolic rewiring and communication in cancer immunity

Immunological Aspects of Cancer Cell Metabolism

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

The cancer metabolic reprogramming and immune response

Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeutics

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

Altered cancer metabolism in mechanisms of immunotherapy resistance

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Metabolic crosstalk in the breast cancer microenvironment

Metabolic regulation in the immune response to cancer

Immunometabolism: a new dimension in immunotherapy resistance

Immunometabolism: A Novel Perspective of Liver Cancer Microenvironment and Its Influence on Tumor Progression

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy